Suppression of human immunodeficiency virus replication during acute measles

Journal of Infectious Diseases

Volumn 185, Issue 8, 2002, Pages 1035-1042

  Moss, William J ^a   Ryon, Judith J ^a   Monze, Mwaka ^d   Cutts, Felicity ^e,f   Quinn, Thomas C ^b,c   Griffin, Diane E ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d UNIVERSITY TEACHING HOSPITAL   (Zambia)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 16; INTERLEUKIN 2 RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES; TUMOR NECROSIS FACTOR RECEPTOR 2; VIRUS RNA;

ACUTE DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSTIMULATION; INFANT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEASLES; MEASLES VIRUS; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SUPERINFECTION; T LYMPHOCYTE SUBPOPULATION; VIRUS INHIBITION; VIRUS LOAD; VIRUS REPLICATION;

ACUTE DISEASE; ANTIGENS, CD; CD4 LYMPHOCYTE COUNT; CHILD, PRESCHOOL; FEMALE; HIV; HUMANS; INFANT; MACROPHAGE INFLAMMATORY PROTEIN-1; MALE; MEASLES; RANTES; RECEPTORS, INTERLEUKIN-2; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RNA, VIRAL; VIRUS REPLICATION;

EID: 0037090114     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/340027     Document Type: Article

References (66)

1. Effect of superimposed infections on viral replication in human immunodeficiency virus type 1-infected children
2. The impact of active herpes simplex virus infection on human immunodeficiency virus load
3. Changes in virus load markers during AIDS-associated opportunistic diseases in human immunodeficiency virus-infected persons
4. Effect of Mycobacterium tuberculosis on HIV replication: Role of immune activation
5. Effects of influenza vaccination in HIV-infected adults: A double-blind, placebo-controlled trial
6. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1
7. Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine
8. Hepatitis B vaccination and plasma HIV-1 RNA
9. T cell activation and human immunodeficiency virus replication after influenza immunization of infected children
10. Activation of virus replication after vaccination of HIV-1-infected individuals
11. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination
12. HIV-1 viraemia and influenza
13. Effect of immune activation on the dynamics of human immunodeficiency virus replication and on the distribution of viral quasispecies
14. The effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults
15. Impact of opportunistic diseases on survival in patients with HIV disease
16. Accelerated course of human immunodeficiency virus infection after tuberculosis
17. Human herpesvirus 6 inhibits human immunodeficiency virus type 1 replication in cell culture
18. Human herpesvirus 6 infects dendritic cells and suppresses human immunodeficiency virus type 1 replication in coinfected cultures
19. Inhibition of human immunodeficiency virus type 1 replication prior to reverse transcription by influenza virus stimulation
20. Influenza virus-stimulated generation of anti-human immunodeficiency virus (HIV) activity after influenza vaccination in HIV-infected individuals and healthy control subjects
21. HIV-1 suppression during acute scrub-typhus infection
22. Global measles control and regional elimination, 1998-1999
23. Severe measles in the tropics. I
24. Cell-mediated immunity during natural measles infection
25. Increased childhood morbidity after measles is short-term in urban Bangladesh
26. Immune activation in measles
27. Immune activation during measles: Interferon-γ and neopterin in plasma cerebrospinal fluid in complicated and uncomplicated disease
28. 2-microglobulin in plasma and cerebrospinal fluid in complicated and uncomplicated disease
29. Dynamics of viral replication in infants with vertically acquired human immunodeficiency virus type 1 infection
30. Age- and time-related changes in extracellular viral load in children vertically infected by human immunodeficiency virus
31. Rapid increases in load of human immunodeficiency virus correlate with early disease progression and loss of CD4 cells in vertically infected infants
32. + lymphocyte count in HIV-infected infants and children
33. Virus levels in untreated African infants infected with human immunodeficiency virus type 1
34. Association of HIV-1 load and CD4 lymphocyte count with mortality among untreated African children over one year of age
35. Measles virus infection in rhesus macaques: Altered immune responses and comparison of the virulence of six different virus strains
36. Acute and long-term changes in T-lymphocyte subsets in response to clinical and subclinical measles. A community study from rural Senegal
37. Differential CD4 T cell activation in measles
38. Cellular immunity and T-lymphocyte subsets in young children with acute measles
39. T helper cell defect related to severity in measles
40. + T cells
41. + lymphocytes can control HIV infection in vitro by suppressing virus replication
42. + T cells
43. IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages
44. Interleukin-16 (IL-16) inhibits human immunodeficiency virus replication in cells from infected subjects, and serum IL-16 levels drop with disease progression
45. Interleukin 16: Implications for CD4 functions and HIV-1 progression
46. Serum chemokine levels in patients with non-progressing HIV infection
47. Serum levels of RANTES and MIP-1α in HIV-positive long-term survivors and progressor patients
48. Chemokine production in HIV-seropositive long-term asymptomatic individuals
49. HIV suppression by interleukin-16
50. IL-16 represses HIV-1 promoter activity
51. + cells transfected with IL-16 cDNA are resistant to HIV-1 infection: Inhibition of mRNA expression
52. C-C chemokines, IL-16, and soluble antiviral factor activity are increased in cloned T cells from subjects with long-term nonprogressive HIV infection
53. In vivo T-lymphocyte activation and transient reduction of viral replication in macaques infected with simian immunodeficiency virus
54. Early prognostic indicators in primary perinatal human immunodeficiency virus type 1 infection: Importance of viral RNA and the timing of transmission on long-term outcome
55. Association of human immunodeficiency virus (HIV) load early in life with disease progression among HIV-infected infants
56. Viral load and disease progression in infants infected with human immunodeficiency virus type 1
57. The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1-infected children
58. Increased serum levels of soluble tumor necrosis factor receptors (sTNF-Rs) in children and adolescents with vertically and horizontally transmitted HIV infection
59. 2-microglobulin and p24 antigen as indicators of disease progression in children with AIDS on zidovudine therapy
60. The prognostic significance in HIV infection of immune activation represented by cell surface antigen and plasma activation marker changes
61. Increased immune activation precedes the inflection point of CD4 T cells and the increased serum virus load in human immunodeficiency virus infection
62. Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurements
63. 2-microglobulin
64. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1
65. Pathogenesis of measles virus infection: An hypothesis for altered immune responses
66. CD4 + and CD8 + lymphocytes and HIV RNA in HIV infection: High baseline counts and in particular rapid decrease of CD8 + lymphocytes predict AIDS